AKArshiya Khan

Arshiya Khan

*This is an algorithmically generated author record based on publicly available information.

Arshiya Khan has a total of 119 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Potential Inhibitors of SARS-CoV-2 Developed through Machine Learning, Molecular Docking, and MD Simulation

    by Arshiya Khan, Anushka Bhrdwaj, Khushboo Sharma, Ravali Arugonda, Navpreet Kaur, Rinku Chaudhary, Uzma Shaheen, Umesh Panwar, V. Natchimuthu, Abhishek Kumar, et al.

    Background: The advent of Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of the Coronavirus Disease 2019 (COVID-19) pandemic, has impacted physical and mental health worldwide. The lack of effective antiviral drugs necessitates a robust therapeutic approach to develop anti-SARS-CoV-2 drugs. Various investigations have recognized ACE2 as the primary receptor of SARS-CoV-2, and this amalgamation of ACE2 with the spike protein of the coronavirus is paramount for viral entry into the host cells and inducing infection. Consequently, restricting the virus';s accessibility to ACE2 offers an alternative therapeutic approach to averting this illness. Objective: The study aimed to identify potent inhibitors with enhanced affinity for the ACE2 protein and validate their stability and efficacy against established inhibitors via molecular docking, machine learning, and MD simulations. Methodology: 202 ACE2 inhibitors (PDB ID and 6LZG), comprising repurposed antiviral compounds and specific ACE2 inhibitors, were selected for molecular docking. The two most effective compounds obtained from docking were further analyzed using machine learning to identify potential compounds with enhanced ACE2-binding affinity. To refine the dataset, molecular decoys were generated through the Database of Useful Decoys: Enhanced (DUD-E) server, and Singular Value Decomposition (SVD) was applied for data preprocessing. The Tree-based Pipeline Optimization Tool (TPOT) was then utilized to optimize the machine learning pipeline. The most promising ML-predicted compounds were re-evaluated through docking and subjected to Molecular Dynamics (MD) simulations to evaluate their structural stability and interactions with ACE2. Finally, these compounds were evaluated against the top two pre-established inhibitors using various computational tools. Results: The two best pre-established inhibitors were identified as Birinapant and Elbasvir, while the best machine-learning-predicted compounds were PubChem ID: 23658468 and PubChem ID: 117637105. Pharmacophore studies were conducted on the most effective machine-learning-predicted compounds, followed by a comparative ADME/T analysis between the best ML-screened and pre-established inhibitors. The results indicated that the top ML compound (PubChem ID: 23658468) demonstrated favorable BBB permeability and a high HIA index, highlighting its potential for therapeutic applications. The ML-screened ligand demonstrated structural stability with an RMSD (0.24 nm) and greater global stability (Rg: 2.08 nm) than Birinapant. Hydrogen bonding interactions further validated their strong binding affinity. MM/PBSA analysis confirmed the ML-screened compound';s stronger binding affinity, with a binding free energy of - 132.90 kcal/mol, indicating enhanced stability in complex formation. Conclusion: The results emphasize the efficacy of integrating molecular docking, machine learning, and molecular dynamics simulations in facilitating the rapid identification of novel inhibitors. PubChem ID: 23658468 demonstrates robust binding affinity to ACE2 and favorable pharmacokinetic properties, establishing it as a promising candidate for further investigation.


  • Top Cited Papers
    Open Access

    Characterization and optimization of azo dyes degrading microbes isolated from textile effluent

    by Arshiya Khan, Anuraj Nayarisseri, Sanjeev Kumar Singh

    Azo dyes are highly recalcitrant, persistent, and toxic compounds, extensively used in the textile industry. The untreated discharge of dye effluents from the textile industry poses severe environmental and health risks. This research aimed to isolate and identify bacterial strains from textile wastewater that can decolorize azo dyes. After the subsequent screening of 89 isolates, 4 novel strains were identified utilizing the 16S rRNA gene sequencing technique that could effectively decolorize and degrade azo dyes, methyl red, direct yellow 12, and acid black 210. A thorough assessment of physicochemical parameters was conducted to optimize for maximum decolorization for all four strains. At pH 7, 37° C, and 50 mg/L dye concentration, the maximum decolorization for methyl red, direct yellow 12, and acid black 210 was 79.09% > 72.20% > 64.76%; 84.45% > 62.59% > 54.29%; 83.12% > 70.22% > 61.42%; and 92.71% > 83.02% > 69.84%, for isolate 1, isolate 2, isolate 3, and isolate 4, respectively. The novel strains belonged to the Sphingomonas, Pseudomonas, Shewanella, and Priestia species. The unique sequences of these bacterial strains have been submitted to the GenBank database under the accession numbers “OQ202071”, “PP708911”, “PP708909”, and “PP086977,” respectively. Further, an enzyme study and statistical optimization of Priestia flexa species was performed. A Central Composite Design and Response Surface Methodology has been applied for synergistic effects of process parameters namely pH (5–9), initial dye concentration (100–250 mg/L), and temperature (25°–45° C) on the decolorization of the model dyes. The regression analysis indicated a strong correlation between the experimental data and the second-order polynomial supported by a high coefficient of determination (R²). For all three dyes analyzed, the difference between the experimental and predicted values was found to be less than 10%. Fourier Transform Infrared spectroscopy was further employed to analyze and confirm the degradation of the three dyes.


  • Identification and Characterization of Biosurfactant-producing Novel Paenibacillus dendritiformis Strain ANSKLAB02 from Brackish River Water

    by Anuraj Nayarisseri, Anushka Bhrdwaj, Khushboo Sharma, Arshiya Khan, Sanjeev Kumar Singh

    Introduction: Biosurfactants are the surface-active reagents produced by microorgan-isms, which exhibit the non-toxic and augmented bioavailability potential for the decomposition of petro-based pollutants and performing microbial-enhanced oil recovery (MEOR). Methods: Thus, the present study entails the isolation of a novel biosurfactant-producing bacteria in MSM medium containing crude oil as a sole carbon source. Biosurfactant screening, cultural, and statistical optimization; Plackett - Burman Design, and response surface methodology (RSM) in conjunction with the Box-Behnken experimental design was employed for examining the bio-surfactant producing potential, and emulsification activity of the Paenibacillus strain, which ren-dered a maximum E24 index as 70%, with reduced surface tension of 29 mN/m. Result: The novel isolate was identified and named Paenibacillus dendritiformis strain AN-SKSLAB02 and the sequence was deposited in the NCBI-GenBank database with accession num-ber “KU518891”. Conclusion: The results signify that the bacterium holds the potential to burgeon in harsh condi-tions which is an appropriate habitat for application in MEOR, which has great potential to aid in environmental cleanup.


  • Contributors

    by K.O. Mohammed Aarif, Mohammed Baba Abdulkadir, Shaban Ahmad, Ahmad A.L. Ahmad, Sheik Jamil Ahmed, Tanveer Ahmed, Kizhakkeppurath Kumaran Ajeeshkumar, Sarra Akermi, Afroj Alam, Raiyan Ali, et al.

  • Navigating the genomic landscape: A deep dive into clinical genetics with deep learning

    by Manmeet Kaur, Vandana Singh, Arshiya Khan, Khushboo Sharma, Francisco Jaime Bezerra Mendoonca Junior, Anuraj Nayarisseri


  • Unveiling the ESR1 Conformational Stability and Screening Potent Inhibitors for Breast Cancer Treatment

    by Khushboo Sharma, Umesh Panwar, Maddala Madhavi, Isha Joshi, Ishita Chopra, Lovely Soni, Arshiya Khan, Anushka Bhrdwaj, Abhyuday Singh Parihar, Vineeth Pazharathu Mohan, et al.

    Background: The current study recognizes the significance of estrogen receptor alpha (ERα) as a member of the nuclear receptor protein family, which holds a central role in the pathophysiology of breast cancer. ERα serves as a valuable prognostic marker, with its established relevance in predicting disease outcomes and treatment responses. Methods: In this study, computational methods are utilized to search for suitable drug-like compounds that demonstrate analogous ligand binding kinetics to ERα. Results: Docking-based simulation screened out the top 5 compounds - ZINC13377936, NCI35753, ZINC35465238, ZINC14726791, and NCI663569 against the targeted protein. Further, their dynamics studies reveal that the compounds ZINC13377936 and NCI35753 exhibit the highest binding stability and affinity. Conclusion: Anticipating the competitive inhibition of ERα protein expression in breast cancer, we envision that both ZINC13377936 and NCI35753 compounds hold substantial promise as potential therapeutic agents. These candidates warrant thorough consideration for rigorous In vitro and In vivo evaluations within the context of clinical trials. The findings from this current investigation carry significant implications for the advancement of future diagnostic and therapeutic approaches for breast cancer.